4-((n-acetyl-l-tyrosyl)amino)benzoic-acid and Exocrine-Pancreatic-Insufficiency

4-((n-acetyl-l-tyrosyl)amino)benzoic-acid has been researched along with Exocrine-Pancreatic-Insufficiency* in 4 studies

Other Studies

4 other study(ies) available for 4-((n-acetyl-l-tyrosyl)amino)benzoic-acid and Exocrine-Pancreatic-Insufficiency

ArticleYear
Measurement of extra-pancreatic secretory function by 13C-dipeptide breath test.
    Translational research : the journal of laboratory and clinical medicine, 2007, Volume: 149, Issue:6

    A simple breath test was developed for assessment of exocrine pancreatic function employing 13C-dipeptide [ie, benzoyl-L-tyrosyl-[1-(13)C]alanine (Bz-Tyr-Ala)], and this test was examined to determine whether it can be used to diagnose exocrine pancreatic insufficiency in patients with chronic pancreatitis. The subjects, 24 patients with chronic pancreatitis and 16 healthy adult controls, underwent the Bz-Tyr-Ala breath test, in which breath samples were collected every 10 min up to 90 min after oral administration of an aqueous solution of 5-mg/kg Bz-Tyr-Ala (7 mM). They also underwent a breath test with [1-(13)C]alanine equimolar to that contained in Bz-Tyr-Ala and the N-benzoyl-L-tyrosyl-p-aminobenzoic acid (BT-PABA) test. Delta13CO2 values at 10-60 min for the Bz-Tyr-Ala breath test were significantly lower in chronic pancreatitis patients than in normal controls. However, the [1-(13)C]alanine breath test results did not differ between patients and normal controls. The correlation coefficient between the Bz-Tyr-Ala breath test Delta13CO2 value at 20 min, and the results of the BT-PABA test were r=0.726 (r2=0.527, P<0.0001). The results suggest that this newly developed Bz-Tyr-Ala breath test can quickly and noninvasively diagnose the exocrine pancreatic dysfunction.

    Topics: 4-Aminobenzoic Acid; Aged; Breath Tests; Carbon Isotopes; Dipeptides; Exocrine Pancreatic Insufficiency; Female; Humans; Male; Middle Aged; Pancreas, Exocrine; Pancreatic Function Tests; Pancreatitis, Chronic; para-Aminobenzoates; Reproducibility of Results; ROC Curve

2007
[Modified ALTAB test in the diagnosis of exocrine pancreatic insufficiency].
    Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten, 1985, Volume: 45, Issue:6

    The indirect estimation of chymotrypsin by the tubeless ALTAB-test was performed in 17 patients with well-defined exocrine pancreatic insufficiency, 10 of them after operation for chronic pancreatitis. In comparison with 12 healthy subjects the test proved to be a non-expensive, certain and specific method for detection of moderate and severe exocrine insufficiency. It exists positive correlations with the secretin-pancreocymine-test and with the maximal stimulable secretion of insulin. Therefore the ALTAB-test after operations with modified anatomy of the gastro-intestinal tract especially is able to substitute extensive testing of secretion in screening and controlling of progression. The value of the 3-hour serum level of PABA corresponds to the urine output within 6 hours. There are such advantages like independence from the kidney-function, avoidance of incomplete urine-collection and a considerable reduced test-time too.

    Topics: 4-Aminobenzoic Acid; Aminobenzoates; Chronic Disease; Exocrine Pancreatic Insufficiency; Humans; Pancreatic Function Tests; Pancreatitis; para-Aminobenzoates; Postoperative Complications

1985
[Determination of the external secretory function of the pancreas with a peroral test using the chymotrypsin substrate 4-(N-acetyl-L-tyrosyl) aminobenzoic acid. A methodological study].
    Casopis lekaru ceskych, 1981, Aug-27, Volume: 120, Issue:34

    Topics: 4-Aminobenzoic Acid; Adult; Aged; Aminobenzoates; Exocrine Pancreatic Insufficiency; Female; Humans; Male; Middle Aged; Pancreatic Function Tests; para-Aminobenzoates

1981
A new method of testing pancreatin therapy in vivo by the use of a peroral chymotrypsin substrate 4-(N-acetyl-L-tyrosyl)aminobenzoic acid.
    Hepato-gastroenterology, 1980, Volume: 27, Issue:3

    The efficacy of pancreatin in vivo was determined in 14 patients with advanced pancreatic insufficiency using a peroral test with 2 g of chymotrypsin substrate, 4-(N-acetyl-L-tyrosyl)aminobenzoic acid, the Lundh test meal and 1000 ml tea. Chymotrypsin hydrolysis was quantified by 4-aminobenzoic acid excreted in 6-hr or 8-hr urine samples. After a control test without pancreatin, one or two tablets of Panpur (Nordmark-700 mg of pancreatin and 50 mg of bile per tablet) were applied simultaneously with the Lundh meal on repeated examinations. The urinary excretion of 4-aminobenzoic acid was restored to normal values in 5 subjects during both sampling periods. With this method, stimulated and substituted chymotrypsin is measured at the same time. The conditions of the tests, both with and without pancreatin replacement, are fully comparable and thus the significance of factors modifying the activity of enzymic components in the digestive tube is limited. The method appears appropriate for the institution of an effect pancreatin therapy and its control in vivo.

    Topics: 4-Aminobenzoic Acid; Adult; Aged; Aminobenzoates; Bile; Chymotrypsin; Drug Combinations; Exocrine Pancreatic Insufficiency; Female; Food; Humans; Male; Middle Aged; Pancreatin; para-Aminobenzoates; Tissue Extracts; Tyrosine; Water

1980